Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder.

Severus WE, Littman AB, Stoll AL.

Harv Rev Psychiatry. 2001 Nov-Dec;9(6):280-93. Review.

PMID:
11600487
2.

Homocysteine lowering and cardiovascular disease risk: lost in translation.

Marcus J, Sarnak MJ, Menon V.

Can J Cardiol. 2007 Jul;23(9):707-10. Review.

3.

Homocysteine lowering with folic acid and B vitamins in vascular disease.

Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators..

N Engl J Med. 2006 Apr 13;354(15):1567-77. Erratum in: N Engl J Med. 2006 Aug 17;355(7):746.

4.

Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction.

Ciaccio M, Bellia C.

Curr Clin Pharmacol. 2010 Feb;5(1):30-6. Review.

PMID:
20236081
6.

[Nutritional medicine 2007].

Hauner H.

Dtsch Med Wochenschr. 2007 Jun 22;132(25-26):1411-3. Review. German. No abstract available.

PMID:
17570092
8.

[Hyperhomocysteinemia and cardiometabolic risk].

Vannucchi H, Melo SS.

Arq Bras Endocrinol Metabol. 2009 Jul;53(5):540-9. Review. Portuguese.

9.

Homocysteine trials--clear outcomes for complex reasons.

Loscalzo J.

N Engl J Med. 2006 Apr 13;354(15):1629-32. No abstract available.

PMID:
16531615
10.

Total homocysteine concentration and associated cardiovascular and renal implications in adults.

Bergen C, Compher C.

J Cardiovasc Nurs. 2006 Jan-Feb;21(1):40-6. Review.

PMID:
16407736
11.

[Risk factors for cardiovascular diseases: what is the role for homocysteine?].

Bendini MG, Lanza GA, Mazza A, Giordano A, Leggio M, Menichini G, De Cristofaro R, Moriconi E, Cozzari L, Farina SM, Giordano G.

G Ital Cardiol (Rome). 2007 Mar;8(3):148-60. Review. Italian.

PMID:
17461357
12.
14.

Homocysteine lowering and cardiovascular events after acute myocardial infarction.

Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K; NORVIT Trial Investigators..

N Engl J Med. 2006 Apr 13;354(15):1578-88.

15.

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M.

Z Kardiol. 2004 Jun;93(6):439-53. Review.

PMID:
15252738
16.

Emergent cardiovascular risk factor: homocysteine.

Warren CJ.

Prog Cardiovasc Nurs. 2002 Winter;17(1):35-41. Review.

PMID:
11872979
17.
18.

Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases.

de Bree A, Mennen LI, Hercberg S, Galan P.

Eur J Clin Nutr. 2004 May;58(5):732-44.

PMID:
15116076
19.

Homocysteine and cardiovascular disease.

Refsum H, Ueland PM, Nygård O, Vollset SE.

Annu Rev Med. 1998;49:31-62. Review.

PMID:
9509248
20.

Homocysteine and cardiovascular disease: a review of the evidence.

Wierzbicki AS.

Diab Vasc Dis Res. 2007 Jun;4(2):143-50. Review.

PMID:
17654449
Items per page

Supplemental Content

Support Center